Julie Krystal

9PUBLICATIONS
57CO-AUTHORS
Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 02, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.

Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois

|Jan 18, 2024
A phase 1 study of mebendazole with bevacizumab and irinotecan in high-grade gliomas.

Julie Krystal, Derek Hanson, Danielle Donnelly

|Nov 30, 2023
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

Erica Brivio, Edoardo Pennesi, Marieke E Willemse

|Aug 26, 2023
Treatment of High-Risk Neuroblastoma.

Julie Krystal, Jennifer H Foster

|Jul 23, 2022
New pediatric leukemia/lymphoma diagnoses during the COVID-19 pandemic: A New York perspective.

Layne J Silver, Pooja Desai, Sareen Shah

|Apr 09, 2022
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma.

Tom Rosenberg, Kee Kiat Yeo, Audrey Mauguen

Pageof 2

Frequent Collaborators

2 joint publications

Theodore W Laetsch

2 joint publications

Steven G DuBois

2 joint publications

Gregory K Friedman

1 joint publications

Christian M Zwaan